HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
GlobeNewswire
· Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of..
Medical University of Vienna
News and Video Search Results
News coverage
-
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
ACN Newswire
-
G.ST Antivirals reports start of Phase II trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer
EQS Group
-
3D-Printed Brain Phantom Pioneers Advanced Research in Neurodegenerative Diseases
Energy Daily
-
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
GlobeNewswire
0 shares
1 views
You might like
Medical University of Vienna media coverage
Mice study unravels new insights to boost treatment of liver fibrosis
IndiaTimes
Austrian researchers at Medical University of Vienna study genes in mouse models with liver disease, uncovering insights into liver..
-
CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer
EQS Group
-
Biotechnology Industry Insights: Comprehensive Report on Collaboration Deals from 2019-2024 Now Available
GlobeNewswire
-
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings
PR Newswire Asia
-
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
GlobeNewswire
Advertisement
More coverage
Clinical Research on Photon-Counting CT Begins with Radboud University Medical Center
GlobeNewswire
Otawara, Japan, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Canon Medical Systems Corporation (hereinafter "Canon Medical"; President and..
-
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
GlobeNewswire
-
JOHNSON & JOHNSON MEDTECH LAUNCHES NEW PRESBYOPIA-CORRECTING INTRAOCULAR LENS TECNIS PURESEE IN EMEA
GlobeNewswire
-
Discoverer of the Klotho Gene and Pioneer in Longevity and Disease Prevention Dr. Makoto Kuro-o Joins Scientific Advisory Board of ADvantage Therapeutics
GlobeNewswire
-
G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose against upper respiratory infections
EQS Group